Digital Transformation in the PLM domain - distrib.pdf
Aagami Case Study - Assessment of Global Net Present Value (NPV) of a revolutionary Nanotechnology Based Diagnostic Platform
1. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Global NPV of Technology (in USD Million)
(P) Pessimistic Scenario
Discount rate 8.60%
Year 2012 2013 2014 2015 2016 2017 2018
Time 0 1 2 3 4 5 6
Revenue from Sale of NPTP POC devices - - 20.30 23.62 32.06 40.80 24.93
Revenue from Sale of Treated Cuvette - - 450.00 614.87 815.48 1,021.15 657.19
Total Cost of NPTP POC devices - - 4.10 5.66 7.69 9.78 5.98
Total Cost of Treated Cuvettes - - 175.00 387.88 514.43 644.17 414.57
Commercialisation Costs 400.00 - - - - - -
Total Cash Inflow - - 470.30 638.49 847.54 1,061.96 682.11
Total cash Outflow 400.00 - 179.10 393.54 522.12 653.96 420.55
Net Cash Flow -400.00 - 291.20 244.95 325.43 408.00 261.56
Discount Factor 1.00 0.92 0.85 0.78 0.72 0.66 0.61
Discounted Cash Flow -400.00 - 246.91 191.24 233.96 270.09 159.44
NPV 1,524.77
Client wanted to commercialize ground breaking
technology in the MI Diagnostics field, and wanted to
know its commercial potential so that suitable
licensing fees and model could be determined and
also value could be showcased to Licensees
Investors Controlled Innovative technology company
Aagami involved a team of a senior consultant part
time and a business analyst full time to conduct
primary and secondary research involving domain
specialists to capture current market scenario.
Performed competitive benchmarking to assess a
Relative Cost Benefit Index used later for determining
technology platform (product) pricing.
Projected annual demand for next ten years in three
different scenarios - Median, Optimistic and
Pessimistic across multiple disease categories.
Forecasted Global Average Selling Price (ASP) and
Cost associated with capex and opex
Validated commercializing options and measured
incremental financial scenario for potential licensees
Determined the Global Net Present Value (NPV) and
created Financial models
NPV of the technology and indicative licensing fees,
along with several insights generated, served as
conclusive guidance to the client for deal-making
and negotiations.
The client was delighted which also resulted in
repeat assignments